Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.07.2022 | Case report

Methotrexate

Worsening kidney function: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kuhlman JJ, et al. Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 12: 23-29, 14 Apr 2022. Available from: URL: http://doi.org/10.2147/BLCTT.S360442 Kuhlman JJ, et al. Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 12: 23-29, 14 Apr 2022. Available from: URL: http://​doi.​org/​10.​2147/​BLCTT.​S360442
Metadaten
Titel
Methotrexate
Worsening kidney function: 2 case reports
Publikationsdatum
01.07.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-20234-2

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Caffeine

Case report

Colchicine

Case report

Bexarotene

Case report

Eltrombopag